Bioresorbable Polymers Market Size, Share & Analysis | 2031
Bioresorbable Polymers Market Size, Share & Analysis | 2031
Segments - Bioresorbable Polymers Market by Product (Polylactic Acid [Poly (L-Lactic Acid) and Poly (DL-Lactide)], Polysaccharides, Polyglycolic Acid, Polycaprolactone, and Others), Application (Orthopedics, Drug Discovery, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :MC-5738
| 4.7 Rating
| 56 Reviews
| 187 Pages
| Format :
Report Description
Bioresorbable Polymers Market Outlook 2031.
The global bioresorbable polymers market size was USD 1.30 Billion in 2022 and is likely to reach USD 3.65 Billion by 2031, expanding at a CAGR of 13.9% during, 2023–2031. The market growth is attributed to the increasing demand for drug delivery applications.
High demand for drug delivery applications is anticipated to drive the bioresorbable polymers market during the forecast period. These polymers are widely used in the biomedical sector for drug delivery applications such as surgical implant devices, and wound healing products. They are derived from lactide, glycolide, trimethylene carbonate, p-dioxanone, and caprolactone.
Drug discovery applications in bioresorbable polymers are still in the early stages of development. Researchers have developed a bioresorbable polymer-based drug delivery system that delivers chemotherapeutic agents directly to the tumor site.
- In September 2023, Zeus launched Absorv XSE-oriented tubing is available in a variety of resins and extended size ranges, Absorv XSE provides a highly customizable platform for design and an alternative to metallic products permanently implanted in the human body.
The market report finds that the COVID-19 pandemic hindered the bioresorbable polymers market, due to the strict regulations imposed by the government. Disruption of the supply chain, social distancing, and shutdown of manufacturer companies affected the market.
Bioresorbable Polymers Market Dynamics
Major Drivers
Increasing demand for bioresorbable polymers in the healthcare industry is expected to boost the market in the coming years. Bioresorbable polymers are used for fracture fixation in orthopedic surgery.
Orthopedic implants include suture anchors, interference screws, meniscals, and plates. These implants are mostly used as resorbable implants for shoulder surgery, anterior cruciate ligament, fracture care, and meniscal repair.
These polymers are used to make implants as they remove the need for a second surgery to take out the implants and eliminate the risks associated with the second surgery thereby increasing the adoption of the market in implant surgeries.
Existing Restraints
High cost of bioresorbable polymers than conventional polymers is expected to hamper the market. Bioresorbable polymers are more expensive as they are produced in minimal quantities, which increases the production cost. However, they offer a one-time solution and better-quality services.
The cost of these polymers is also influenced by the type of feedstock used during manufacturing. These polymers are manufactured through the polymerization of bio-based raw materials through engineered industrial processes.
Emerging Opportunities
Increasing application of 3D scaffold printing for tissue engineering is expected to create lucrative opportunities for the market players. 3D scaffold printing is a valuable tool in tissue engineering that enables the production of complex structures with specific shapes.
Bioresorbable polymers are materials that have gained significant attention in tissue engineering due to their ability to degrade over time and be replaced by new tissue. The combination of 3D scaffold printing and bioresorbable polymers has led to the development of advanced materials for tissue engineering applications.
-
In February 2020, Evonik introduced the world’s first bioresorbable polymers in powder form for 3D printing of implantable medical devices. The powder is suitable for high-resolution printing of implantable medical devices on selective laser sintering (SLS) equipment. RESOMER PrintPowder is a free-flowing powder with tight specifications and optimized particle size distribution for efficient processability.
Scope of Bioresorbable Polymers Market Report
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Bioresorbable Polymers Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product (Polylactic Acid [Poly (L-Lactic Acid) and Poly (DL-Lactide)], Polysaccharides, Polyglycolic Acid, Polycaprolactone, and Others), and Application (Orthopedics, Drug Discovery, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott; Ashland; Foster Corporation; Futerro; KLS Martin Group; Nomisma Healthcare Pvt. Ltd; Poly-Med Incorporated; REVA Medical, LLC; and Zeus Company Inc |
Bioresorbable Polymers Market Segment Insights
Product Segment Analysis
Based on product, the bioresorbable polymers market is divided into polylactic acid, polysaccharides, polyglycolic acid, polycaprolactone, and others. The polylactic acid segment is further attributed to the poly (l-lactic acid) (PLLA) and poly (dl-lactide) (PDLLA).
The polylactic acid segment is expected to expand at a significant pace during the projection period, as they are carbon-neutral, non-toxic, and 100% renewable. Polylactic acid (PLA) is a biodegradable polymer that is widely used in the production of bioresorbable polymers.
PLA is a sustainable alternative to petroleum-based plastics and is safe to decompose after use without polluting the environment. It has properties such as physical, mechanical, processability, and biocompatibility that make it suitable for industrial usage.
It is also in equivalence with other conventional plastics such as PP, and PET. Poly (L-lactide) (PLLA) is another biodegradable polymer that is used to fabricate resorbable medical devices that degrade in physiological conditions.
Application Segment Analysis
On the basis of application, the global market is segregated into orthopedics, drug discovery, and others. The orthopedics segment is projected to register a considerable CAGR during the forecast period, owing to the high demand for high- quality medical care, rising prevalence of orthopedic disorders, and increasing awareness regarding bioresorbable stents in various countries worldwide.
Lactide and glycolide-based bioresorbable polymers have the most expansive development and subsequent clinical use in orthopedic applications. Calcium-based materials are used in orthopedic applications.
- In February 2022, The 87th Medical Group partnered with Keller Army Community Hospital to expand advanced orthopedic care to service members that are assigned to Joint Based McGuire-Dix-Lakehurst, New Jersey.
Regional Analysis
In terms of region, the global bioresorbable polymers market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the presence of a well-developed healthcare system and rising product consumption in drug delivery and orthopedics applications.
The regional market growth is further attributed to the high demand for quality medical care and increasing research & development activities in the healthcare industry, particularly in the US.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the increasing consumer awareness, rising incidence of chronic diseases, and growing disposable income. The regional market growth is attributed to the increasing geriatric population, increasing implementation of favorable government initiatives, and the presence of high-growth economies such as China, India, and Japan.
Segments
The global bioresorbable polymers market has been segmented on the basis of
Product
- Polylactic Acid
- Polysaccharides
- Polyglycolic Acid
- Polycaprolactone
- Others
Application
- Orthopedics
- Drug Discovery
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the global bioresorbable polymers market are Abbott; Ashland; Foster Corporation; Futerro; KLS Martin Group; Nomisma Healthcare Pvt. Ltd; Poly-Med Incorporated; REVA Medical, LLC; and Zeus Company Inc.
These key players adopt various strategies including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.
- In August 2022, Ashland introduced a strategically significant expansion of its Viatel bioresorbable polymer manufacturing and research & development site at the National Science Park, home to a network of advanced organizations, in Ireland. These polymers are used to provide enhanced treatment solutions for several chronic diseases and are the advanced building blocks in long-acting release formulations, tissue engineering scaffolds, and bioresorbable medical devices.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioresorbable Polymers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bioresorbable Polymers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bioresorbable Polymers Market - Supply Chain
4.5. Global Bioresorbable Polymers Market Forecast
4.5.1. Bioresorbable Polymers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bioresorbable Polymers Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Bioresorbable Polymers Market Absolute $ Opportunity
5. Global Bioresorbable Polymers Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Bioresorbable Polymers Market Size and Volume Forecast by Applications
5.3.1. Orthopedics
5.3.2. Drug Discovery
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Bioresorbable Polymers Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Bioresorbable Polymers Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Bioresorbable Polymers Demand Share Forecast, 2019-2026
7. North America Bioresorbable Polymers Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Bioresorbable Polymers Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Bioresorbable Polymers Market Size and Volume Forecast by Applications
7.4.1. Orthopedics
7.4.2. Drug Discovery
7.4.3. Others
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Bioresorbable Polymers Demand Share Forecast, 2019-2026
8. Latin America Bioresorbable Polymers Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Bioresorbable Polymers Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Bioresorbable Polymers Market Size and Volume Forecast by Applications
8.4.1. Orthopedics
8.4.2. Drug Discovery
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Bioresorbable Polymers Demand Share Forecast, 2019-2026
9. Europe Bioresorbable Polymers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Bioresorbable Polymers Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Bioresorbable Polymers Market Size and Volume Forecast by Applications
9.4.1. Orthopedics
9.4.2. Drug Discovery
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Bioresorbable Polymers Demand Share Forecast, 2019-2026
10. Asia Pacific Bioresorbable Polymers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Bioresorbable Polymers Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Bioresorbable Polymers Market Size and Volume Forecast by Applications
10.4.1. Orthopedics
10.4.2. Drug Discovery
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Bioresorbable Polymers Demand Share Forecast, 2019-2026
11. Middle East & Africa Bioresorbable Polymers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Bioresorbable Polymers Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Bioresorbable Polymers Market Size and Volume Forecast by Applications
11.4.1. Orthopedics
11.4.2. Drug Discovery
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Bioresorbable Polymers Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Bioresorbable Polymers Market: Market Share Analysis
12.2. Bioresorbable Polymers Distributors and Customers
12.3. Bioresorbable Polymers Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott
12.4.2. Ashland
12.4.3. Foster Corporation
12.4.4. Futerro
12.4.5. KLS Martin Group
12.4.6. Nomisma Healthcare Pvt. Ltd
12.4.7. Poly-Med Incorporated
12.4.8. REVA Medical, LLC
12.4.9. Zeus Company Inc
Methodology
Related Reports
Some other reports from this category!
Our Clients
